Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of Chang'ankang Capsule in Chronic Ulcerative Colitis
CTR20132370Phase 2Completed
- Sponsor
- Huaxia Yisheng
- Start
- Jan 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bifidobacterium infantis + lactobacillus acidophilus + enterococcus faecalis in autoimmune colitis, sponsored by Huaxia Yisheng. Started Jan 2015; status: completed.
02
Drugs
bifidobacterium infantis + lactobacillus acidophilus + enterococcus faecalis
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20132370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132370.